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Dr Ling and colleagues performed a large prospective 
study, including 308 patients with major trauma, and 
determined that the genotype distribution of the IL-10 
polymorphisms was associated with the sepsis morbidity 
rate and multiple organ dysfunction syndrome (MODS) 
scores [1]. Th  e authors also investigated the association 
of polymorphisms with lipopolysaccharide-induced IL-
10 production.
Cytokine production varies between individuals, due to 
genetic background and certain allelic variants of cyto-
kine genes – in particular, SNPs are associated with higher 
or lower cytokine production. Th  e IL-10 5´-ﬂ  anking 
region, which controls transcription, is polymorphic, 
with two microsatellites and three SNPs (–1082, –819, 
and –592) [2]. Polymorphisms in the regulatory region of 
the IL-10 gene may inﬂ  uence its expression, and hence 
could inﬂ  uence the susceptibility of sepsis [3].
Th  e authors investigated the hypothesis that SNPs 
located in the cis-regulatory region of IL-10 promoter 
might represent a risk factor or a protective factor for 
developing sepsis and might inﬂ  uence the MODS score 
after major trauma. Th   e results obtained by Dr Ling and 
colleagues demonstrated that both the –1082A and 
–592A alleles were signiﬁ   cantly associated with lower 
lipopolysaccharide-induced IL-10 production in an 
allele-dose-dependent fashion. In contrast, there was no 
signiﬁ  cant diﬀ  erence for association between the –819 
polymorphism and induced cytokine production. Th  ese 
results are in agreement with the data from Turner and 
colleagues, who found that the IL-10 –1082A allele is 
associated with lower in vitro IL-10 production by 
concanavalin-A-stimulated peripheral blood mono  nuclear 
cells from normal subjects [2]. Moreover, Stanilova and 
colleagues reported that carriage of at least one copy of 
the IL-10 –1082A allele in sepsis patients as well as in 
healthy controls resulted in a statistically signiﬁ  cant 
decrease of IL-10 production from stimulated peripheral 
blood mononuclear cells, regardless of the stimuli used 
[4].
Altered host defense mechanisms are considered 
important for the development of sepsis and septic shock. 
Proinﬂ  ammatory and anti-inﬂ  ammatory responses contri-
bute to the development and outcome of severe sepsis 
[5]. Cytokines play a pivotal role in the regulation of the 
type and magnitude of the immune response, and the 
polymorphic nature of the cytokine genes may confer 
ﬂ  exibility on the immune response. Th  e gene encoding 
IL-10 cytokine involved in the modulation of inﬂ  am-
matory responses as a main anti-inﬂ  ammatory agent is 
therefore a candidate gene for determination of the 
human genetic background, which is responsible for 
inter individual  diﬀ   erences in susceptibility to sepsis 
development. Previous reports have indicated that 
increased IL-10 production might be associated with the 
susceptibility and outcome of the sepsis [6-8]. Th  e 
polymorphism at position –1082 in the promoter region 
of the IL-10 gene has been studied by Shu and colleagues, 
who reported an association of this polymorphism with 
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The induced production of proinfl  ammatory and 
anti-infl  ammatory cytokines is considered important 
for the development of sepsis and its sequelae. 
Polymorphisms in the IL-10 gene promoter could 
infl  uence its expression and sepsis susceptibility. 
Results obtained by Dr Ling and colleagues 
demonstrated that the –1082A allele was signifi  cantly 
associated with lower lipopolysaccharide-induced 
IL-10 production in an allele-dose-dependent fashion. 
They also showed that this polymorphism was 
signifi  cantly associated with sepsis development after 
major trauma. These and other research data clearly 
demonstrated that the –1082 A/G polymorphism in 
the IL-10 gene promoter has an important impact on 
susceptibility of sepsis and sepsis outcome.
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© 2010 BioMed Central Ltdsusceptibility to severe sepsis – in contrast to the other 
two linked IL-10 polymorphisms (–592 and –819) in the 
same gene region [9]. Stanilova and colleagues showed that 
the A allele of the –1082 polymorphism in the IL-10 gene 
promoter is associated with sepsis susceptibility, whereas 
the G allele is asso  ciated with higher stimulated IL-10 
production and increased mortality in severe sepsis [4].
Ling and colleagues also showed that, unlike the –1082 
polymorphism, the –819 and –592 polymorphisms were 
not signiﬁ  cantly associated with the sepsis morbidity rate 
and MODS scores. Th   ese collective data clearly 
demonstrated that the –1082 A/G polymorphism in the 
IL-10 gene has an important impact on susceptibility of 
sepsis and sepsis outcome. Th  is  eﬀ  ect is due to the anti-
inﬂ  ammatory and immunoregulatory properties of IL-10. 
Th  e excess of IL-10 production in trauma patients or 
other critically ill patients determined by the –1082G 
allele could be responsible for inducing immuno-
suppression and subse  quently developing bacterial sepsis 
and MODS. Th   e concentration of IL-10 in the blood – in 
most respects, lipopolysaccharide-induced IL-10 – is 
indicative for the magnitude of the inﬂ  ammatory stress 
during sepsis and has been shown to correlate with both 
the severity and outcome of sepsis.
Whether cytokine determination and genotyping in 
critically ill patients could optimize treatment and sepsis 
outcome should be determined by further randomized 
studies.
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